Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary morphine during primary PCI for STEMI
IRCT20220814055685N1Phase 3Completed
- Sponsor
- Qom University of Medical Sciences
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Intracoronary morphine with Placebo (2 arms). Primary endpoint: Coronary reperfusion. Started Dec 2022; status: completed.
02
Drugs
morphine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20220814055685N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220814055685N1.